Schisandra Schisandra chinensis (Turcz.) Baill.
Also called: wu wei zi, five-flavored fruit, omija
Schisandra is a climbing vine whose fruit, wu wei zi ("five-flavored fruit"), has a long history in traditional Chinese medicine as a tonic and for liver and stomach complaints. Supplements use fruit extracts; a related species, Schisandra sphenanthera, is also used.
- Category
- Botanical
- Part used
- Fruit
- Strongest evidence
- C Limited
- Native range
- Native from the Russian Far East to northern China and central Japan (POWO: "Russian Far East to N. China and Central Japan")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. This entry cites 3 RCTs of Schisandra chinensis extract alone versus placebo (sources [2], [3], [4]), 36 to 54 participants. The omija-soybean trial (source [5]) tested a mixture and is not counted. [2]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CHormones and reproduction2 topics
CLiver1 topic
CBlood sugar and weight1 topic
CMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Muscle strength in adults over 50 doing low-intensity exercise | C | A 12-week placebo-controlled trial in 54 adults (1 g extract daily) found greater knee-extensor strength gains; muscle mass, inflammatory and antioxidant markers did not differ. [2] |
| Quadriceps strength in postmenopausal women | C | A 12-week placebo-controlled trial in 45 women (1,000 mg extract daily) reported increased quadriceps strength and lower resting lactate; other measures did not differ. [3] |
| Menopausal symptoms | C | In a placebo-controlled trial (6 weeks of treatment, 12 weeks of follow-up; 36 women completed), Kupperman Index scores were lower with a Schisandra chinensis extract. [4] |
| Blood glucose in adults with mild hyperglycemia (omija and soybean mixture) | C | A 12-week placebo-controlled trial in 80 adults found lower fasting and post-meal glucose with an omija-soybean extract mixture; schisandra alone was not tested. [5] |
| Liver function measures | C | Small uncontrolled studies in liver transplant patients and chronic hepatitis suggested improved liver tests; MSK calls them inconclusive and notes schisandra can lower ALT and AST readings. [1] |
Main constituents: Lignans, notably schisandrin A and schisantherins [1]; Polysaccharides; an anthocyanin identified as responsible for its antioxidant activity [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- 1 g of extract per day for 12 weeks in a muscle-strength trial in adults over 50. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines3 listed
Tacrolimus; P-glycoprotein substrates; CYP1A2, CYP3A4 and CYP3A5 substrates
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- No serious side effects have been reported, but schisandra is not well studied in humans; in one small trial, sleepiness and cold extremities occurred in both treatment and placebo groups. [1]
- No participant experienced adverse events in a 12-week trial of 1 g extract daily. [2]
- Lab-test interaction: schisandra can reduce ALT and AST levels without changing bilirubin. [1]
Interactions
| With | What happens |
|---|---|
| Tacrolimus | In liver transplant patients, schisandra increased blood levels of tacrolimus. [1] |
| P-glycoprotein substrates | Lab and human studies suggest schisandra can inhibit P-glycoprotein and may interfere with the handling of certain drugs. [1] |
| CYP1A2, CYP3A4 and CYP3A5 substrates | Lignans inhibit CYP3A4/3A5 in vitro; animal studies suggest inhibition of CYP3A4 and 1A2, while long-term use can induce CYP3A4. Clinical relevance not yet determined. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Health Canada's TCM ingredients monograph lists Schisandra chinensis fruit (wu wei zi) and Schisandra sphenanthera fruit (nan wu wei zi) as separate ingredients. [7]
Regulatory status
- US: FDA states that, by law, it does not approve dietary supplements before they are marketed; firms are responsible for the safety and labeling of their products. [8]
- Canada: Schisandra chinensis fruit is listed in Health Canada's Traditional Chinese Medicine Ingredients monograph (May 29, 2026). [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Lignans (e.g., schisandrin A, schisantherins) Lignans [P3]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming schisandra: NDI 1319, submitted 2023-12-19 (schisandra fruit extract powder). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC classification of schisandra (Schisandra chinensis) was found in the IARC Monographs list of classifications (Volumes 1–142, list updated 2026-07-23; checked 2026-10-29). [P2]
- No NTP technical report (2-year study) on schisandra (Schisandra chinensis) was found in NTP's list of technical reports (checked 2026-10-29). [P6]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Tacrolimus: Increased tacrolimus blood levels in liver transplant patients. [P3]
- P-glycoprotein substrates: Lab and human studies suggest P-glycoprotein inhibition. [P3]
- CYP1A2, CYP3A4 and CYP3A5 substrates: Inhibition in vitro and in animals; long-term use can induce CYP3A4. Clinical relevance not yet determined. [P3]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) unless FDA grants an exemption petition under 111.75(a)(1)(ii) [P5]
- Species identity (Schisandra chinensis versus S. sphenanthera fruit) — Health Canada lists the two species' fruits as distinct ingredients (wu wei zi and nan wu wei zi) [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- Memorial Sloan Kettering Cancer Center. About Herbs: Schisandra (last updated June 3, 2022), 2022-06-03. mskcc.org
- Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- National Toxicology Program. Technical Reports (list of TR studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Schisandra (last updated June 3, 2022), 2022-06-03. mskcc.org
- Cho YH, et al. Effect of Schisandra chinensis Baillon extracts and regular low-intensity exercise on muscle strength and mass in older adults: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2021;113(6):1440-1446 (PMID 33710261), 2021-06-01. pubmed.ncbi.nlm.nih.gov
- Park J, et al. Effect of Schisandra chinensis extract supplementation on quadriceps muscle strength and fatigue in adult women: a randomized, double-blind, placebo-controlled trial. Int J Environ Res Public Health 2020;17(7):2475 (PMID 32260466), 2020-04-04. pubmed.ncbi.nlm.nih.gov
- Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric 2016;19(6):574-580 (PMID 27763802), 2016-12. pubmed.ncbi.nlm.nih.gov
- Kim DS, et al. Efficacy and safety of Omija (Schisandra chinensis) extract mixture on the improvement of hyperglycemia: a randomized, double-blind, and placebo-controlled clinical trial. Nutrients 2022;14(15):3159 (PMID 35956334), 2022-07-30. pubmed.ncbi.nlm.nih.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Schisandra chinensis (Turcz.) Baill. (accessed 2026-10-29; native range: "Russian Far East to N. China and Central Japan"), 2026-10-29. powo.science.kew.org
- Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.